Literature DB >> 21474386

Drug-resistant temporal lobe epilepsy is associated with postural control abnormalities.

S Colnat-Coulbois1, G C Gauchard, L Maillard, J P Vignal, H Vespignani, J Auque, Ph P Perrin.   

Abstract

Epilepsy is responsible for falls that are not systematically associated with seizures and that therefore suggest postural impairment. There are very few studies of postural control in patients with epilepsy and none of them focus on temporal lobe epilepsy (TLE), although part of the vestibular cortex is located in the temporal cortex. The aim of this study was to evaluate the characteristics of postural control in a homogeneous population of patients with complex partial TLE. Twenty-six patients with epilepsy and 26 age-matched healthy controls underwent a sensory organization test combining six conditions, with and without sensory conflicting situations. Patients with epilepsy displayed poorer postural control, especially in situations where vestibular information is necessary to control balance. In addition to potential antiepileptic drug side effects, vestibular dysfunction could be related to the temporal pathology. Our study allows for a better understanding of the mechanism underlying falls in this population of patients.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21474386     DOI: 10.1016/j.yebeh.2011.02.024

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  2 in total

1.  Impairments in path integration, rotational memory and balancing in patients with temporal lobe epilepsy.

Authors:  Milos Dordevic; Julia Gruber; Friedhelm C Schmitt; Notger Mueller
Journal:  BMJ Neurol Open       Date:  2020-09-21

2.  No significant improvement in neuromuscular proprioception and increased reliance on visual compensation 6 months after ACL reconstruction.

Authors:  Frank Wein; Laetitia Peultier-Celli; Floris van Rooij; Mo Saffarini; Philippe Perrin
Journal:  J Exp Orthop       Date:  2021-03-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.